TickerFactsScreenerDevelopers

10x Genomics, Inc. (TXG) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2017: $47.86M2018: $65.08M2019: $424.17M2020: $663.60M2021: $587.45M2022: $219.75M2023: $359.28M2024: $344.07M$344.07M
2017Cash & Equivalents (USD)2024
Fiscal YearCash & EquivalentsChange YoY
2024$344.07M-4.2%
2023$359.28M+63.5%
2022$219.75M-62.6%
2021$587.45M-11.5%
2020$663.60M+56.4%
2019$424.17M+551.8%
2018$65.08M+36.0%
2017$47.86M—